Omeros (OMER) Tezkor likvidlik

omeros.com - OMER emitenti grafik logotipi

Omeros Corporation noyob kasalliklarni davolashga bag'ishlangan iste'dodli immunologlar va bioximikalarni birlashtiradi. GURU.Markets platformasidagi narxlar dinamikasida aks etgan bozor holati, kompaniya o'zining CNS terapiya platformasini rivojlantirayotgani va narsoplimab uchun tasdiqni kutayotgani sababli 1.94 ko'rsatkichini qayd etdi. Biroq, biznes faqat bitta oftalmologiya mahsulotiga tayanadi, tadqiqot va ishlanmalar (R&D) xarajatlari hamda huquqiy xarajatlar o'rtacha moliyaviy risklarni yuzaga keltirmoqda.

omeros.com (OMER) Tezkor likvidlik ko‘rsatkichi: 04.07.2022 - 31.10.2026 davri uchun

Omeros Corporation (OMER) - koʻrsatkichlar kesimi va moliyaviy hisobotlar

- bozor qiymati va tahlilchilarning maqsadli prognozi:
Narx grafigi omeros.com|OMER - Oʻrtacha prognoz narxi
- bozor kapitallashuvi tafsilotlari:
Bozor qiymati Omeros Corp.|OMER - Korxonaning umumiy qiymati
- balans kapitallashuvi bo'yicha ma'lumotlar:
Bitta aksiya uchun sof aktivlar Omeros|OMER - Kompaniyaning sof aktivlari|Bozor kapitallashuvining balans qiymatiga nisbati omeros.com|OMER - Kompaniya aktivlari
- kompaniyaning majburiyatlari va likvidligi ma'lumotlari:
Qarzning xususiy kapitalga nisbati Omeros Corporation|OMER - Uzoq muddatli qarzning kapitalga koeffitsiyenti|Qisqa muddatli qarzning o'z kapitaliga nisbati omeros.com|OMER - Kompaniyaning umumiy yig'indi qarzi|Qarzning balans kapitallashuviga nisbati Omeros Corp.|OMER - Uzoq muddatli qarz hajmi|Kompaniyaning qisqa muddatli majburiyatlari Omeros|Tezkor likvidlik koeffitsiyenti omeros.com
- foyda va bozor multiplikatorlari tafsilotlari:
OMER - Sof daromad
Kompaniyaning har tomonlama tahlili:Omeros Corporation
omeros.com ishlab chiqargan mahsulot

Omeros Corporation (OMER) uchun geosiyosiy xavflar va neyro-dori komponentlari logistikasidagi uzilishlar operatsion xarajatlarni keskin oshirishi mumkin. Bunday sharoitlarda, tezkor likvidlik koeffitsiyenti illikvid zaxiralarni hisobga olmaydi va faqat naqd pul hamda debitorlik qarzdorliklarini baholaydi. Ushbu konservativ yondashuv kompaniyaning aktivlarni favqulodda sotmasdan qisqa muddatli majburiyatlarini bajarishga bo'lgan haqiqiy qobiliyatini ochib beradi. Qat'iy majburiyatlarni qoplash koeffitsiyenti tahlili investorlarni to'lov qobiliyatini past baholamaslik haqida ogohlantiradi.

Omeros Corporation (OMER) raqobatchilari

Biogen Corp (BIIB) - Tezkor likvidlik|Shoshilinch likvidlik Neurocrine Corp (NBIX)|Tezkor likvidlik Regencell Bioscience|Shoshilinch likvidlik axsome.com AXSM|Tezkor likvidlik ACADIA Pharmaceuticals Inc. (ACAD)|Tezkor likvidlik ko‘rsatkichi Xenon Pharmaceuticals Inc. XENE|Tezkor likvidlik koeffitsiyenti VKTX (Viking Pharma)|Supernus Corp (SUPN) - Shoshilinch likvidlik|CPRX - Tezkor likvidlik|Oraliq qoplash koeffitsiyenti DNLI (denalitherapeutics.com)|Harmony Biosciences Holdings, Inc. (HRMY) - Tezkor likvidlik|Shoshilinch likvidlik Biohaven Ltd (BHVN)|Tezkor likvidlik Amylyx|Trevi Corp (TRVI) - Oraliq qoplama koeffitsiyenti|Tezkor likvidlik ko‘rsatkichi PRAX (Praxis Precision Medicines)|AVXL (anavex.com) - Oraliq qoplash koeffitsiyenti|Tezkor likvidlik koeffitsiyenti CBLL (CeriBell)|PRTA - Tezkor likvidlik ko‘rsatkichi|ALEC - Tezkor likvidlik|Shoshilinch likvidlik Annexon Biosciences Inc.|Neurogene Inc. (NGNE) - Tezkor likvidlik|acimmune.com - Oraliq qoplash koeffitsiyenti|Tezkor likvidlik Voyager Therapeutics, Inc.|Neumora - Kritik likvidlik koeffitsiyenti|Tezkor likvidlik Scilex Holding Co. (SCLX)|TVGN - Shoshilinch likvidlik|Tezkor likvidlik Alpha Cognition Inc. ACOG|Oraliq qoplash koeffitsiyenti CGTX|Inhibikase Therapeutics, Inc. - Tezkor likvidlik koeffitsiyenti|SAVA - Tezkor likvidlik koeffitsiyenti|ASRT (assertiotx.com) - Tezkor likvidlik ko‘rsatkichi|COYA: Oraliq likvidlik koeffitsiyenti|VTGN (VistaGen Therapeutics, Inc.) - Tezkor likvidlik koeffitsiyenti|Ovid Rx (OVID) - Oraliq qoplama koeffitsiyenti|Tezkor likvidlik Acumen Pharmaceuticals, Inc. (ABOS)|CRVO - Shoshilinch likvidlik|Tezkor likvidlik Alterity Therapeutics Limited ATHE|CLNN: Shoshilinch likvidlik koeffitsiyenti|PEPG - Tezkor likvidlik|Shoshilinch likvidlik Jupiter Neurosciences, Inc.|Relmada Therapeutics, Inc. (RLMD) - Tezkor likvidlik|Tezkor likvidlik ko‘rsatkichi Annovis Bio Inc|GRCE (Grace Therapeutics Inc) - Tezkor likvidlik koeffitsiyenti|Shoshilinch likvidlik Firefly Neuro AIFF|Tezkor likvidlik Klotho Neurosciences Inc (KLTO)|NRSN (neurosense-tx.com) - Oraliq qoplash koeffitsiyenti|Tezkor likvidlik Reviva Pharmaceuticals Holdings, Inc. RVPH|MTVA: Shoshilinch likvidlik koeffitsiyenti|NeurAxis, Inc - Tezkor likvidlik koeffitsiyenti|Shoshilinch likvidlik Helius Medical|PASG (passagebio.com) - Tezkor likvidlik ko‘rsatkichi|Neuphoria Therapeutics (NEUP) - Tezkor likvidlik koeffitsiyenti|Tezkor likvidlik Minerva Neurosciences, Inc.|ATHA: Oraliq qoplash koeffitsiyenti|Tezkor likvidlik Addex Therapeutics, Ltd. (ADXN)|ALZN - Shoshilinch likvidlik|Tezkor likvidlik Cyclerion Therapeutics, Inc. CYCN|Protagenic Therapeutics Inc. (PTIX) - Shoshilinch likvidlik|KTTA - Tezkor likvidlik|Cortigent, Inc. (CRGT) - Tezkor likvidlik ko‘rsatkichi|ATXI: Tezkor likvidlik koeffitsiyenti|Shoshilinch likvidlik BrainStorm Cell Therapeutics Inc. (BCLI)|Tezkor likvidlik Cara Therapeutics, Inc.|CHRO: Oraliq qoplash koeffitsiyenti|Tezkor likvidlik Eliem Therapeutics (ELYM)|ITCI - Shoshilinch likvidlik|Tezkor likvidlik Longboard Pharma LBPH|Oraliq qoplama koeffitsiyenti Marinus Pharma (MRNS)|NKGN: Tezkor likvidlik ko‘rsatkichi|Oraliq qoplash koeffitsiyenti NRBO (neurobopharma.com)|SAGE: Tezkor likvidlik koeffitsiyenti|Tezkor likvidlik ko‘rsatkichi Synaptogenix Inc.|Tezkor likvidlik Trevena, Inc|Shoshilinch likvidlik Vigil Neuro VIGL|Tezkor likvidlik Anew Medical (WENA)|CERE (cerevel.com) - Oraliq qoplash koeffitsiyenti